GO:0015730 propanoate transmembrane transport: Short-Chain Fatty Acid Transport, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015730 (propanoate transmembrane transport) describes the directed movement of propionate into, out of, or within a cell by transporters or pores.
• Propionate is a short-chain fatty acid produced by gut microbiota that modulates inflammation, systemic cytokines, and microbial ecology in hosts.
• Transport of propionate across membranes is mediated by specific carrier proteins and can be studied using bacterial and mammalian models.
• Dysregulation of short-chain fatty acid transport impacts cystic fibrosis, inflammatory diseases, and cancer metabolism.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of propionate transporter genes.
• Combining metabolomics, transport assays, and transcriptomics provides a multi-layered view of propanoate transmembrane transport.
Description
Propanoate transmembrane transport (GO:0015730) is the biological process by which propionate, a three-carbon short-chain fatty acid, is moved across cellular membranes by dedicated transporters or pores. This process is essential for the uptake, distribution, and elimination of propionate in both prokaryotic and eukaryotic cells, and it influences host-microbe interactions, metabolic signaling, and immune regulation. In the gut, microbial fermentation produces large quantities of propionate, which must be transported into host cells to exert its biological effects. Understanding the molecular players and regulatory logic of propanoate transmembrane transport is therefore central to microbiome research, metabolic disease, and drug development. Research on propanoate transmembrane transport spans microbiology, physiology, and cell biology. Bacterial systems such as Aromatoleum aromaticum EbN1T respond to lignin-derived phenylpropanoids, which are structurally related to propionate, by inducing transport and catabolic pathways. In mammalian systems, propionate transport across intestinal epithelia and into immune cells modulates inflammation and systemic cytokine levels, as shown in a mouse model of cystic fibrosis. These findings highlight the importance of identifying the specific transporters and regulatory networks that govern propionate movement. Despite its importance, the exact molecular identity of many propionate transporters remains incompletely defined, and the mechanistic details of transport are still being resolved. This article integrates authoritative GO annotation with verified literature to provide a research-grade overview of GO:0015730, covering its definition, core mechanisms, key genes, disease relevance, and experimental strategies for CRISPR-based interrogation.
propanoate transmembrane transport At A Glance
| GO ID | GO:0015730 |
|---|---|
| GO term | propanoate transmembrane transport |
| Ontology | biological_process |
| Synonym | propanoate transport; propionate transport |
| Major function | Directed movement of propionate across cellular membranes via transporters or pores |
| Related molecules | Short-chain fatty acid transporters, membrane carrier proteins, and associated regulatory factors |
| Biological context | Gut microbial fermentation, host-microbe interaction, metabolic signaling, and immune modulation |
| Research relevance | Target for microbiome, metabolic disease, cystic fibrosis, and cancer studies |
What Is GO:0015730?
GO:0015730, propanoate transmembrane transport, is defined by QuickGO as the directed movement of propionate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. In other words, it is the process that moves the short-chain fatty acid propionate across biological membranes, either into or out of a cell, using dedicated transport proteins or channels.
Why Is propanoate transmembrane transport Important in Cell Biology?
Propanoate transmembrane transport is critical because propionate is a major microbial metabolite that influences host immunity, energy metabolism, and intestinal homeostasis. Defects in propionate transport can alter systemic cytokine profiles and microbial ecology, contributing to diseases such as cystic fibrosis and inflammatory disorders. Moreover, understanding how propionate enters and exits cells provides a foundation for therapeutic strategies that target short-chain fatty acid signaling in cancer and metabolic disease.
• Propionate is a key short-chain fatty acid produced by gut bacteria and transported into host cells to modulate inflammation.
• Transport of propionate affects systemic cytokine levels and microbial ecology in cystic fibrosis models.
• Bacterial responses to phenylpropanoids, structurally related to propionate, involve dedicated transport and catabolic systems.
• Propionate transport is linked to metabolic signaling pathways that influence cell proliferation and immune cell function.
• Dysregulated short-chain fatty acid transport is implicated in inflammatory bowel disease and metabolic syndrome.
• Cancer cells can reprogram amino acid and metabolite transport, and propionate transport may intersect with these pathways.
• CRISPR-based models allow causal testing of candidate propionate transporter genes.
• Transport assays combined with metabolomics can quantify propionate flux across membranes.
• Understanding propionate transport can inform probiotic and postbiotic strategies.
• GO:0015730 provides a standardized annotation for comparative genomics and functional studies.
What Happens During propanoate transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first recognizes and grabs propionate on one side of the membrane.
Propanoate transmembrane transport begins when a membrane-embedded transporter or pore recognizes propionate as a substrate. In bacterial systems, exposure to lignin-derived phenylpropanoids induces transport systems that recognize structurally related aromatic compounds, suggesting broad substrate recognition mechanisms. In mammalian systems, short-chain fatty acid transporters mediate the uptake of propionate from the gut lumen into epithelial cells, a step that is essential for host-microbe signaling.
Conformational change and translocation
In simple terms: The transporter changes shape to carry propionate across the membrane.
After binding, the transporter undergoes conformational changes that move propionate across the lipid bilayer. Structural and mechanistic studies of related transporters, such as the bacterial heme transporter, reveal complex conformational cycles that couple substrate binding to translocation. Similar principles likely apply to propionate transporters, although the exact structural details for propionate-specific carriers remain to be fully resolved.
Release and intracellular distribution
In simple terms: Once inside, propionate is released and distributed to cellular compartments.
Following translocation, propionate is released into the cytoplasm or other cellular compartments where it can be metabolized or act as a signaling molecule. In the gut, propionate transported into host cells can modulate cytokine production and immune cell function, as demonstrated in a mouse model of cystic fibrosis. The intracellular fate of propionate depends on downstream metabolic enzymes and signaling pathways.
Regulation by environmental and host factors
In simple terms: The transport process can be turned up or down by signals from the environment or the host.
Propanoate transmembrane transport is regulated by environmental cues and host factors. In Aromatoleum aromaticum EbN1T, the presence of lignin-derived phenylpropanoids induces transport and catabolic gene expression. In mammalian hosts, microbial ecology and inflammatory status influence propionate transport and its systemic effects, as shown by modulation of cytokines in cystic fibrosis mice. These regulatory layers ensure that propionate flux matches metabolic demand and immune context.
Integration with cellular metabolism
In simple terms: Transported propionate feeds into metabolic pathways that affect the whole cell.
Once inside the cell, propionate can enter metabolic pathways such as propionate catabolism or serve as a signaling molecule. In cystic fibrosis mouse models, propionate produced by intestinal Bacteroides modulates inflammation and systemic cytokines, indicating that transport is tightly linked to host metabolic and immune responses. This integration highlights the importance of propanoate transmembrane transport in whole-organism physiology.
Key Genes Involved in GO:0015730 propanoate transmembrane transport
The following genes and proteins are implicated in propanoate transmembrane transport or related short-chain fatty acid transport processes, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LAT1 (SLC7A5) | Amino acid transporter that can influence metabolite transport | Structural and pharmacological studies; anticancer drug recognition |
| ABCC1 (MRP1) | Multidrug resistance protein with transport activity | Mutational analysis of transmembrane helices affecting transport |
| HssS | Sensor kinase involved in heme sensing and signaling | Two-component system signaling in Staphylococcus aureus |
| Bacterial heme transporter | Model for conformational complexity in transport | Mechanistic studies of membrane transport |
| Aromatoleum aromaticum EbN1T transport genes | Response to lignin-derived phenylpropanoids | Bacterial aromatic compound transport and catabolism |
| Bacteroides spp. propionate production genes | Propionate synthesis and host interaction | Gut microbiome modulation of inflammation |
| SLC family transporters | Short-chain fatty acid transport | Candidate propionate transporters in mammalian cells |
| MCT family transporters | Monocarboxylate transport | Potential propionate transport in epithelia |
| SMCT family transporters | Sodium-coupled monocarboxylate transport | Potential propionate uptake in intestine |
| CFTR | Chloride channel affected in cystic fibrosis | Model for studying propionate effects in CF |
| IL-6 | Cytokine modulated by propionate | Inflammation readout in CF models |
| TNF-alpha | Cytokine modulated by propionate | Systemic inflammation marker |
| PPAR gamma | Nuclear receptor involved in metabolic signaling | Potential downstream target of propionate |
| HDAC inhibitors | Propionate acts as HDAC inhibitor | Epigenetic regulation by propionate |
| GPR41/43 | Short-chain fatty acid receptors | Propionate sensing and signaling |
| SLC16A1 | Monocarboxylate transporter | Candidate for propionate transport |
| SLC5A8 | Sodium-coupled monocarboxylate transporter | Potential propionate transporter |
| SLC22A family | Organic anion transporters | Potential propionate transport |
How Is propanoate transmembrane transport Regulated?
Propanoate transmembrane transport is regulated at multiple levels. In bacteria, the presence of lignin-derived phenylpropanoids induces the expression of transport and catabolic genes, as shown in Aromatoleum aromaticum EbN1T. In mammalian systems, host inflammatory status and microbial ecology influence propionate transport and its systemic effects; for example, intestinal Bacteroides modulates inflammation and cytokines via propionate in a cystic fibrosis mouse model. Additionally, transport activity can be regulated by post-translational modifications and membrane trafficking, although specific mechanisms for propionate transporters require further study.
propanoate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Bacteroides propionate genes | Cystic fibrosis, gut inflammation | Mouse model of cystic fibrosis with Bacteroides colonization |
| LAT1 (SLC7A5) | Triple-negative breast cancer | JPH203 treatment in TNBC models |
| ABCC1 | Multidrug resistance | TM6 and TM17 mutants in transport assays |
| CFTR | Cystic fibrosis | CF mouse models and intestinal organoids |
| SLC transporters | Metabolic disorders | Knockout and overexpression cell lines |
Cystic fibrosis and gut inflammation
In a mouse model of cystic fibrosis, intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate, indicating that propanoate transmembrane transport is directly linked to disease severity and host immune responses. Defects in propionate transport could exacerbate inflammatory phenotypes in cystic fibrosis.
Cancer metabolism and immune microenvironment
Targeting amino acid transporters such as LAT1 with JPH203 reduces triple-negative breast cancer proliferation and reshapes the suppressive immune microenvironment by blocking essential amino acid uptake. Although this study focuses on amino acids, it highlights how transporter-mediated metabolite flux can influence cancer progression and immunity, a principle that may extend to propionate transport.
Metabolic and inflammatory disorders
Propionate is a short-chain fatty acid with anti-inflammatory properties, and its transport into host cells is required for modulating systemic cytokines. Dysregulated propionate transport may contribute to metabolic syndrome and inflammatory bowel disease, although direct evidence in humans is still emerging.
From propanoate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for propionate transport? | CRISPR knockout cell line or mouse model |
| Does a specific mutation alter transport activity? | Point mutation knock-in via CRISPR |
| Can a transporter be tagged for localization studies? | Tagged knock-in using CRISPR |
| Does overexpression increase propionate uptake? | Overexpression cell line |
| Which genes are regulated by propionate exposure? | Transcriptomics in bacterial or mammalian cells |
| How does propionate affect immune cells? | Co-culture and cytokine profiling |
How to Study the propanoate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled transport assay | Uptake and efflux rates | Quantifying propionate transport kinetics |
| RNA-seq | Gene expression changes | Identifying regulated transporters |
| Metabolomics | Metabolite levels | Measuring propionate and downstream metabolites |
| Site-directed mutagenesis | Functional impact of specific residues | Mapping transporter active sites |
| Structural biology (cryo-EM/X-ray) | Three-dimensional structure | Understanding transport mechanism |
| Cytokine profiling | Immune response | Assessing inflammation in CF models |
| Microbiome sequencing | Microbial ecology | Linking propionate producers to host phenotypes |
Transport assays
Radiolabeled or fluorescent propionate analogs can be used to measure transport kinetics across membranes in cell lines or vesicles. Such assays help quantify uptake and efflux rates and identify transporter specificity.
Transcriptomics and metabolomics
RNA-seq and metabolomics can reveal changes in gene expression and metabolite levels upon propionate exposure. In Aromatoleum aromaticum EbN1T, transcriptomics identified genes induced by lignin-derived phenylpropanoids, providing a model for studying propionate-related transport.
Structural biology and mutagenesis
Structural studies of related transporters, such as the bacterial heme transporter, inform mechanistic models of propionate transport. Site-directed mutagenesis of transmembrane helices, as performed for ABCC1, can identify residues critical for transport activity.
In vivo models
Mouse models of cystic fibrosis and microbiome colonization allow assessment of propionate transport effects on inflammation and systemic cytokines. These models are essential for translating in vitro findings to organismal physiology.
How CRISPR Can Be Used to Study GO:0015730 propanoate transmembrane transport
Knockout
CRISPR knockout of candidate propionate transporter genes can abolish transport activity, providing causal evidence for their role in GO:0015730. Such models are useful for testing whether loss of a specific transporter affects propionate uptake and downstream inflammatory responses.
Point Mutation
Point mutations introduced by CRISPR can mimic naturally occurring variants or disrupt key residues in transporter proteins. For example, mutations in transmembrane helices of ABCC1 alter transport function, and similar approaches can be applied to propionate transporters.
Knock-in
Knock-in of tagged transporters (e.g., GFP or HA) allows visualization and biochemical isolation of propionate transport complexes. This approach is valuable for studying localization and interaction partners in native contexts.
Overexpression
CRISPR activation or cDNA overexpression can increase transporter levels to enhance propionate uptake, enabling gain-of-function studies and drug screening. Overexpression models help determine whether a candidate gene is sufficient to drive transport.
How EDITGENE Supports propanoate transmembrane transport Research
Researchers studying propanoate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in propionate movement across membranes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional interrogation of GO:0015730 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for propanoate transmembrane transport research.
Frequently Asked Questions About propanoate transmembrane transport
What is GO:0015730?
GO:0015730 is the Gene Ontology term for propanoate transmembrane transport, defined as the directed movement of propionate into, out of or within a cell by means of a transporter or pore.
What genes are involved in propanoate transmembrane transport?
Candidate genes include SLC family transporters, MCT family transporters, and bacterial transport systems responsive to phenylpropanoids, though the exact mammalian propionate transporters are still being characterized.
Why is propionate transport important?
Propionate is a microbial metabolite that modulates inflammation and systemic cytokines, and its transport is essential for host-microbe signaling and metabolic regulation.
How is propanoate transmembrane transport studied?
Researchers use transport assays, transcriptomics, metabolomics, structural biology, and CRISPR models to study propionate transport.
What diseases are linked to propionate transport?
Cystic fibrosis, inflammatory bowel disease, and cancer metabolism have been linked to propionate transport and short-chain fatty acid signaling.
Can CRISPR be used to study propionate transporters?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of candidate propionate transporter genes.
What is the role of Bacteroides in propionate transport?
Intestinal Bacteroides produce propionate, which is transported into host cells and modulates inflammation and microbial ecology in cystic fibrosis models.
Are there specific inhibitors of propionate transport?
Specific inhibitors for propionate transporters are not well established, but transport assays can be used to screen for modulators.
How does propionate affect the immune system?
Propionate transported into immune cells can alter cytokine production and reduce inflammation, as shown in mouse models.
What model systems are best for studying propanoate transmembrane transport?
Both bacterial systems like Aromatoleum aromaticum and mammalian models such as cystic fibrosis mice are valuable for studying propionate transport.
Conclusion
Propanoate transmembrane transport (GO:0015730) is a fundamental biological process that governs the movement of the short-chain fatty acid propionate across cellular membranes. It plays critical roles in host-microbe interactions, immune modulation, and metabolic regulation, with implications for cystic fibrosis, cancer, and inflammatory diseases. Despite progress, the molecular identity and regulation of propionate transporters remain active areas of research. By leveraging CRISPR-based models and multi-omics approaches, researchers can dissect the causal roles of candidate genes in propionate transport. EDITGENE offers end-to-end services to accelerate this discovery, from knockout and knock-in models to library screening and bioinformatics support.
References
- 1. Lee Y et al.. 2025. Structural basis of anticancer drug recognition and amino acid transport by LAT1.. Nat Commun 16(1):1635 PMID: 39952931
- 2. Zhao Y et al.. 2025. Targeting LAT1 with JPH203 to reduce TNBC proliferation and reshape suppressive immune microenvironment by blocking essential amino acid uptake.. Amino Acids 57(1):27 PMID: 40379991
- 3. Wu D et al.. 2023. Dissecting the conformational complexity and mechanism of a bacterial heme transporter.. Nat Chem Biol 19(8):992-1003 PMID: 37095238
- 4. Saillant V et al.. 2024. HssS activation by membrane heme defines a paradigm for two-component system signaling in Staphylococcus aureus.. mBio 15(6):e0023024 PMID: 38682935
- 5. Maeno K et al.. 2009. Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1).. Drug Metab Dispos 37(7):1411-20 PMID: 19398503
- 6. Chen L et al.. 2023. New Insights into the Accumulation, Transport, and Distribution Mechanisms of Hexafluoropropylene Oxide Homologues, Important Alternatives to Perfluorooctanoic Acid, in Lettuce (Lactuca sativa L.).. Environ Sci Technol 57(26):9702-9712 PMID: 37314230
- 7. Vagts J et al.. 2021. Responsiveness of Aromatoleum aromaticum EbN1(T) to Lignin-Derived Phenylpropanoids.. Appl Environ Microbiol 87(11) PMID: 33741621
- 8. Price CE et al.. 2024. Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis.. mBio 15(2):e0314423 PMID: 38179971
